Phathom Pharmaceuticals to Highlight VOQUEZNA(R) (vonoprazan) at the American College of Gastroenterology (ACG) 2025 Annual Scientific Meeting GlobeNewswire October 23, 2025 FLORHAM PARK, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) — Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced its participation in the […]

Pacira BioSciences to Present New Data from Three Real-World Studies with EXPAREL(R) GlobeNewswire October 23, 2025 — Findings Presented at AMCP Nexus 2025 Annual Meeting — BRISBANE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of

Collegium to Report Third Quarter 2025 Financial Results on November 6, 2025 GlobeNewswire October 23, 2025 STOUGHTON, Mass., Oct. 23, 2025 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that it will report third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Following the release of the financials,

T1 Energy Inc. Announces Pricing of $72 Million Registered Direct Offering With Existing and New Leading U.S. Institutional Investors GlobeNewswire October 23, 2025 AUSTIN, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) — T1 Energy Inc. (NYSE: TE) (“T1,” “T1 Energy,” or the “Company) today announced that it entered into agreements with existing and new leading institutional

Integra Balance AI showcases cutting-edge AI solutions at CPA America annual leadership retreat 2025 GlobeNewswire October 23, 2025 Phoenix, AZ, Oct. 23, 2025 (GLOBE NEWSWIRE) — Integra Balance AI successfully participated in the CPAConnect Annual Leadership Retreat 2025, held October 19-22 at the Westin Phoenix Downtown. The four-day event brought together accounting industry leaders to

Oncotelic to present at the 2025 San Antonio Breast Cancer Symposium (SABCS) Highlighting Sapu003 (Deciparticle(TM) Everolimus) GlobeNewswire October 23, 2025 Accepted Presentations Showcase First-in-Human Development, Manufacturing Innovation, and Predictive Biomarkers for Deciparticle(TM) Everolimus (Sapu003) AGOURA HILLS, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc. (OTCQB: OTLC), a biopharmaceutical company founded to discover, create,

OFAL Board Approves Share Repurchase Program of up to $2 Million GlobeNewswire October 23, 2025 Los Angeles, Oct. 23, 2025 (GLOBE NEWSWIRE) — OFA Group (the “Company” or “OFAL”) today announced that its Board of Directors has approved a share repurchase program authorizing the Company to buy back up to $2 million of its outstanding

EagleNXT Announces Sale of Advanced eBee TAC Drones to Defense Logistics Agency GlobeNewswire October 23, 2025 Advanced Drones to Fulfill Varied Missions, Increase Flexibility and Capability with multiple sensor packages WICHITA, Kan., Oct. 23, 2025 (GLOBE NEWSWIRE) — AgEagle Aerial Systems Inc. (dba, EagleNXT) (the “Company” or “EagleNXT”) (NYSE: UAVS), a leading provider of advanced

WiMi Studies Hybrid Quantum-Classical Convolutional Neural Network Model GlobeNewswire October 23, 2025 BEIJING, Oct. 23, 2025 (GLOBE NEWSWIRE) — BEIJING, Oct. 23, 2025–WiMi Hologram Cloud Inc. (NASDAQ: WiMi) (“WiMi” or the “Company”), a leading global Hologram Augmented Reality (“AR”) Technology provider, today announced that they are actively exploring a shallow hybrid quantum-classical convolutional neural network

Upexi Welcomes Jon Najarian to the Upexi Advisory Committee Upexi's third Advisory Committee member is an options legend and prominent media personality GlobeNewswire October 23, 2025 TAMPA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) — Upexi, Inc. (NASDAQ: UPXI), a brand owner specializing in the development, manufacturing, and distribution of consumer products with diversification into the